type here...

CATEGORIES

For Practitioners

LATEST

1...789...14Page 8 of 14

TRENDING

EDITORS CHOICE

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

Heart Disease and Depression

John Whyte MD -
Family history. High blood pressure. High cholesterol. Excess weight. These are the risk factors for heart disease that your doctor typically talks to you about.  Yet, there is...

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne -
All claims about treatments affecting human health and well-being should be subject to robust review. That review requires someone to facilitate criticism, locate qualified critics, and bring them into the discussion.

Psychiatry’s “Bible” Panel Comes Under Fire for Funding and Gifts

Pat Farrell PhD -
Pharmaceutical companies frequently pay doctors, and research indicates that these payments have an impact on doctors’ prescription practices. Expressly, doctors may prescribe more expensive name-brand medications...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories